Fundraising FoxApervita
Chicago, US · Founded 2012 · Delaware corporation · 10 known investors
Find your way into Apervita
Sign up to see every warm intro you have to Apervita
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Apervita team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
An online store selling injectable and oral anabolic steroids, HGH, and post-cycle therapy products directly to consumers.
Founders & leadership
Apervita was founded in 2012 by Paul Magelli and Geoff Phillips.
Board
Investors · 10
How we know: Baird Capital's portfolio page · funding news · prnewswire.com · Not right? Tell us
How we know: Bootstrap Venture Partners's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 3
Reported raises · per SEC filings
Form D private placements$22.6M disclosed across 1 of 3 rounds · 2014–2019
▶$22.6MraisedOct 2019 · 17 investors · Other Health CareRule 506(b)
- James BradleyDirector
- Kevin HutchinsonExecutive Officer, Director
- Mark AchlerDirector
- Adam KoopersmithDirector
- Michael LiangDirector
- Kevin WeinsteinExecutive Officer
- Kenneth JakobsenExecutive Officer
- Blackford MiddletonExecutive Officer
- Michael OltmanExecutive Officer
- William McNallyExecutive Officer
- Sarah LondonDirector
- Offering amount
- $22.6M
- Amount sold
- $22.6M
- Minimum investment
- $26.5K
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.5MofferedAug 2017 · Other Health CareRule 506(b)
- Michael LiangDirector
- Blackford MiddletonExecutive Officer
- Michael OltmanExecutive Officer
- Noah LewisDirector
- Paul MagelliExecutive Officer, Director
- Brad RyanExecutive Officer
- David ShreinerExecutive Officer
- David TuttleExecutive Officer
- Offering amount
- $16.5M
- Minimum investment
- $15K
- Finders' fees
- $520K
- Placement agents
- Manor Park Securities LLC
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$26MofferedDec 2014 · Other Health CareRule 506(b)
- Mark AchlerDirector
- Geoff PhillipsExecutive Officer, Director, Promoter
- Paul J MagelliExecutive Officer, Director, Promoter
- Aaron SymanskiExecutive Officer
- Offering amount
- $26M
- Minimum investment
- $25K
- Proceeds to insiders
- $300B
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Apervita.
In the news
Frequently asked questions
- What does Apervita do?
- An online store selling injectable and oral anabolic steroids, HGH, and post-cycle therapy products directly to consumers.
- Who founded Apervita?
- Apervita was founded by Paul Magelli, Geoff Phillips in 2012.
- Who are Apervita's investors?
- Apervita's investors include Baird Capital, Bootstrap Venture Partners, GE Ventures, Graphene Ventures, Optum Ventures, Pritzker Group Venture Capital, Wintrust Ventures.
- How much funding has Apervita raised?
- Apervita has disclosed $22.6M raised across 1 of its 3 known rounds.
- Where is Apervita headquartered?
- Apervita is headquartered in Chicago, US.